Atreca (BCEL) News Today → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free BCEL Stock Alerts $0.09 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 23, 2024 | ca.finance.yahoo.comAtreca, Inc. (BCEL) Stock Price, News, Quote & History - Yahoo FinanceApril 21, 2024 | nz.finance.yahoo.comAtreca, Inc. (0C1.MU)February 18, 2024 | wsj.comAtreca Inc. Cl AFebruary 15, 2024 | benzinga.comAtreca Stock (NASDAQ:BCEL), Short Interest ReportFebruary 7, 2024 | msn.comAtreca Inc Announces Executive Departures and Consulting AgreementsDecember 29, 2023 | bizjournals.comImmunome to buy assets from California biotech companyDecember 26, 2023 | tmcnet.comBCEL Stock Alert: Halper Sadeh LLC Is Investigating Atreca, Inc.December 26, 2023 | marketbeat.comTrading was temporarily halted for "BCEL" at 08:12 AM with a stated reason of "News pending."December 21, 2023 | thestreet.comAtreca Inc.December 11, 2023 | benzinga.comAtreca Stock (NASDAQ:BCEL) Dividends: History, Yield and DatesNovember 16, 2023 | morningstar.comAtreca Inc Class A BCELNovember 14, 2023 | marketwatch.comAtreca to Cut About 40% of WorkforceNovember 14, 2023 | finance.yahoo.comAtreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic AlternativesNovember 2, 2023 | es.investing.comAtreca Inc (BCEL)October 24, 2023 | finance.yahoo.comBAKER BROS. ADVISORS LP Reduces Stake in Atreca IncOctober 12, 2023 | benzinga.comWhat's Going On With Atreca Inc Stock?October 12, 2023 | bizjournals.comMid-Peninsula building rode biotech's boom. Now it's showing how to survive the bustSeptember 21, 2023 | finance.yahoo.comAtreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb CrossAugust 11, 2023 | msn.comHC Wainwright & Co. Downgrades Atreca Inc - (BCEL)August 11, 2023 | msn.comStifel Downgrades Atreca Inc - (BCEL)August 11, 2023 | finance.yahoo.comAtreca Reports Second Quarter 2023 Financial Results and Announces Corporate RestructuringAugust 2, 2023 | msn.comAtreca Inc - (BCEL) Price Target Increased by 11.89% to 10.20June 20, 2023 | msn.comAtreca Approaches A Major Go/No-Go DecisionJune 6, 2023 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Atreca (BCEL)June 5, 2023 | msn.comHC Wainwright & Co. Reiterates Atreca Inc - (BCEL) Buy RecommendationJune 5, 2023 | finance.yahoo.comAtreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual MeetingJune 5, 2023 | markets.businessinsider.comAtreca (BCEL) Gets a Buy from H.C. WainwrightJune 2, 2023 | fool.comAtreca (NASDAQ: BCEL)May 30, 2023 | markets.businessinsider.comStifel Nicolaus Sticks to Their Buy Rating for Atreca (BCEL)May 17, 2023 | ca.finance.yahoo.comAtreca, Inc. (BCEL) Interactive Stock Chart - Yahoo FinanceMay 14, 2023 | ca.finance.yahoo.comAtreca, Inc. (BCEL) Stock Historical Prices & Data - Yahoo FinanceMay 12, 2023 | msn.comHC Wainwright & Co. Reiterates Atreca, Inc. (BCEL) Buy RecommendationMay 11, 2023 | msn.comStifel Maintains Atreca, Inc. (BCEL) Buy RecommendationMay 11, 2023 | finanznachrichten.deAtreca, Inc.: Atreca Reports First Quarter 2023 Financial Results and Recent Corporate DevelopmentsMay 11, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Atreca (BCEL) and Oscar Health (OSCR)May 10, 2023 | finance.yahoo.comAtreca Reports First Quarter 2023 Financial Results and Recent Corporate DevelopmentsApril 26, 2023 | finance.yahoo.comAtreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual MeetingApril 13, 2023 | finance.yahoo.comAtreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual ConferenceApril 6, 2023 | finance.yahoo.comHere's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock NowApril 5, 2023 | finance.yahoo.comAre Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?March 23, 2023 | finance.yahoo.comAtreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023March 21, 2023 | investing.comAtreca (BCEL) Earnings Dates & ReportsMarch 1, 2023 | finance.yahoo.comAtreca to Participate at Cowen’s 43rd Annual Health Care ConferenceFebruary 6, 2023 | finance.yahoo.comAtreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor TargetJanuary 9, 2023 | finance.yahoo.comAtreca Appoints Philippe Bishop, MD as Chief Medical OfficerNovember 10, 2022 | finance.yahoo.comAtreca Reports Third Quarter 2022 Financial Results and Provides Pipeline UpdateOctober 5, 2022 | globenewswire.comAtreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewswireOctober 5, 2022 | finance.yahoo.comAtreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual MeetingSeptember 13, 2022 | streetinsider.comImmPACT Bio Names Jonathan Benjamin, M.D., Ph.D. as Chief Medical Officer - StreetInsider.comSeptember 13, 2022 | prnewswire.comImmPACT Bio Names Jonathan Benjamin, M.D., Ph.D. as Chief Medical Officer - PR Newswire Get Atreca News Delivered to You Automatically Sign up to receive the latest news and ratings for BCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (Ad)Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market… Click here for the details BCEL Media Mentions By Week BCEL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCEL News Sentiment▼0.000.76▲Average Medical News Sentiment BCEL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCEL Articles This Week▼00▲BCEL Articles Average Week Get Atreca News Delivered to You Automatically Sign up to receive the latest news and ratings for BCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: XCUR News Today EVOK News Today GOVX News Today ALZN News Today VIRI News Today SEEL News Today NEXI News Today PHIO News Today PTPI News Today SXTP News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCEL) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atreca, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
